Financials

  • Market Capitalization 10.29 B
  • Employee 295
  • Founded 2016
  • CEO N/A
  • Website www.krystalbio.com
  • Headquarter Pennsylvania, United States
  • FIGI BBG00HDGRHH7
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
46.63
Relación precio/flujo de caja
25.53

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
870
SMMT
Summit Therapeutics Inc. - Common Stock
13.73 USD-4.19%+10.46%+6.02%-30.87%10.95 B USD
890
AXSM
Axsome Therapeutics, Inc. - Common Stock
198.64 USD-0.19%-3.96%-7.82%+52.57%10.40 B USD
910
IONS
Ionis Pharmaceuticals, Inc. - Common Stock
61.05 USD-2.21%0.00%+15.93%-15.36%10.15 B USD
918
CYTK
Cytokinetics, Incorporated - Common Stock
72.09 USD-7.46%-6.91%-6.00%+24.08%10.02 B USD

Noticias